160 related articles for article (PubMed ID: 38380837)
1. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
[TBL] [Abstract][Full Text] [Related]
2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
[TBL] [Abstract][Full Text] [Related]
5. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
Wan Y; Li L; Niu H; Ma X; Yang J; Yuan C; Mu G; Zhang J
Int Heart J; 2017 Aug; 58(4):601-607. PubMed ID: 28701670
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
[TBL] [Abstract][Full Text] [Related]
7. Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis.
Ando T; Okuhara Y; Orihara Y; Nishimura K; Yamamoto K; Masuyama T; Hirotani S
Heart Vessels; 2018 Sep; 33(9):1029-1036. PubMed ID: 29556693
[TBL] [Abstract][Full Text] [Related]
8. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
[TBL] [Abstract][Full Text] [Related]
9. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
[TBL] [Abstract][Full Text] [Related]
10. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
[TBL] [Abstract][Full Text] [Related]
11. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL
JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830
[TBL] [Abstract][Full Text] [Related]
12. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
da Rosa PR; Rohde LE; Doebber M; Ribeiro ALP; Prado DP; Bertoldi EG; Figueiredo Neto JA; Kohler I; Beck-da-Silva L; Danzmann LC; Moura LZ; Rover M; Simões MV; Sant'Anna RT; Biolo A
Am Heart J; 2017 Dec; 194():125-131. PubMed ID: 29223430
[TBL] [Abstract][Full Text] [Related]
13. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
[TBL] [Abstract][Full Text] [Related]
14. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial.
Krim SR; Anand S; Greene SJ; Chen A; Wojdyla D; Vilaro J; Haught H; Herre JM; Eisenstein EL; Anstrom KJ; Pitt B; Velazquez EJ; Mentz RJ
JAMA Cardiol; 2024 Feb; 9(2):182-188. PubMed ID: 37955908
[TBL] [Abstract][Full Text] [Related]
15. Lung ultrasound-guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS-HF study).
Rivas-Lasarte M; Álvarez-García J; Fernández-Martínez J; Maestro A; López-López L; Solé-González E; Pirla MJ; Mesado N; Mirabet S; Fluvià P; Brossa V; Sionis A; Roig E; Cinca J
Eur J Heart Fail; 2019 Dec; 21(12):1605-1613. PubMed ID: 31667987
[TBL] [Abstract][Full Text] [Related]
16. Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Felker GM; Anstrom KJ; Adams KF; Ezekowitz JA; Fiuzat M; Houston-Miller N; Januzzi JL; Mark DB; Piña IL; Passmore G; Whellan DJ; Yang H; Cooper LS; Leifer ES; Desvigne-Nickens P; O'Connor CM
JAMA; 2017 Aug; 318(8):713-720. PubMed ID: 28829876
[TBL] [Abstract][Full Text] [Related]
17. Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center's Experience.
Griffin M; Soufer A; Goljo E; Colna M; Rao VS; Jeon S; Raghavendra P; D'Ambrosi J; Riello R; Coca SG; Mahoney D; Jacoby D; Ahmad T; Chen M; Tang WHW; Turner J; Mullens W; Wilson FP; Testani JM
JACC Heart Fail; 2020 Mar; 8(3):199-208. PubMed ID: 32035891
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
Gilotra NA; Princewill O; Marino B; Okwuosa IS; Chasler J; Almansa J; Cummings A; Rhodes P; Chambers J; Cuomo K; Russell SD
JACC Heart Fail; 2018 Jan; 6(1):65-70. PubMed ID: 29226816
[TBL] [Abstract][Full Text] [Related]
19. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
Frea S; Pidello S; Volpe A; Canavosio FG; Galluzzo A; Bovolo V; Camarda A; Golzio PG; D'Ascenzo F; Bergerone S; Rinaldi M; Gaita F
Clin Res Cardiol; 2020 Apr; 109(4):417-425. PubMed ID: 31256261
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
